Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson’s disease and related disorders: A systematic review and meta-analysis

Author:

Taha Hash Brown1ORCID,Bogoniewski Aleksander1

Affiliation:

1. University of California Los Angeles

Abstract

Abstract Parkinsonian disorders, including Parkinson's disease (PD), multiple system atrophy (MSA), dementia with Lewy body (DLB), corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) are often misdiagnosed due to overlapping symptoms and the absence of precise biomarkers. Furthermore, there are no current methods to ascertain the progression and conversion of prodromal conditions such as REM behavior disorder (RBD). Extracellular vesicles (EVs), containing a mixture of biomolecules, have emerged as potential sources for parkinsonian diagnostics. However, inconsistencies in previous studies have left their diagnostic potential unclear. We conducted a meta-analysis, following PRISMA guidelines, to assess the diagnostic accuracy of general EVs isolated from various bodily fluids, including cerebrospinal fluid (CSF), plasma, serum, urine or saliva, in differentiating patients with parkinsonian disorders from healthy controls (HCs). The meta-analysis included 21 studies encompassing 1,285 patients with PD, 24 with MSA, 105 with DLB, 99 with PSP, 101 with RBD, and 783 HCs. Analyses were conducted only for patients with PD vs. HCs, given the limited number for other comparisons. Using bivariate and hierarchal receiver operating characteristics (HSROC) models, the meta-analysis revealed moderate diagnostic accuracy in distinguishing PD from HCs, with substantial heterogeneity and publication bias detected. The trim-and-fill method revealed at least two missing studies with null or low diagnostic accuracy. CSF-EVs showed better overall diagnostic accuracy, while plasma-EVs had the lowest performance. General EVs demonstrated higher diagnostic accuracy compared to CNS-originating EVs, which are more time-consuming, labor- and cost-intensive to isolate. In conclusion, while holding promise, utilizing biomarkers in general EVs for PD diagnosis remains unfeasible due to existing challenges. The focus should shift toward harmonizing the field through standardization, collaboration, and rigorous validation. Current efforts by ISEV aim to enhance the accuracy and reproducibility of EV-related research through rigor and standardization, aiming to bridge the gap between theory and practical clinical application.

Publisher

Research Square Platform LLC

Reference109 articles.

1. Parkinson disease;Poewe W;Nat Rev Dis Primers,2017

2. Diagnosis and Treatment of Parkinson Disease: A Review;Armstrong MJ;JAMA,2020

3. Surguchov A (2022) Biomarkers in Parkinson’s Disease In Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice, Peplow PV, Martinez B, Gennarelli AT, eds. Humana, Springer.

4. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis;Rizzo G;Neurology,2016

5. How valid is the clinical diagnosis of Parkinson's disease in the community?;Schrag A;J Neurol Neurosurg Psychiatry,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3